Tech Times of New York: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Tech Times of New York.

Press releases published on June 14, 2026

Jun. 14, 2026

ENSG Investor News: If You Have Suffered Losses in Ensign Group, Inc. (NASDAQ: ENSG), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

Indeterminate GlobeNewswire

Jun. 14, 2026

Ascentage Pharma Presents Multiple Clinical Updates at EHA2026 Congress

Indeterminate GlobeNewswire

Jun. 14, 2026

Zymeworks Presents New Phase 1 Data for Folate Receptor Alpha-Targeting ADC ZW191 at ESMO Gynaecological Cancers Congress 2026

Indeterminate GlobeNewswire

Jun. 14, 2026

Crinetics Presents Full Results From Phase 2 Trial of Atumelnant in Congenital Adrenal Hyperplasia (CAH) in Oral Presentation at ENDO 2026

Indeterminate GlobeNewswire

Jun. 14, 2026

Crinetics Presents Long Term Data at ENDO 2026 Confirming PALSONIFY™ (paltusotine) Provides Durable, Consistent Acromegaly Control

Indeterminate GlobeNewswire

Jun. 14, 2026

Orbs Launches On-Chain Execution Infrastructure for Institutional Crypto Trading

Indeterminate GlobeNewswire

Jun. 14, 2026

Stake Launches its Referral Code SHIMA – 200% Bonus and 5% Cashback for New Users in 2026

Indeterminate GlobeNewswire

Jun. 14, 2026

ROSEN, NATIONAL TRIAL ATTORNEYS, Encourages GeneDx Holdings Corp. Investors to Secure Counsel Before Important Deadline in Securities Class Action - WGS

Indeterminate GlobeNewswire

Jun. 14, 2026

Bronstein, Gewirtz & Grossman LLC Urges GeneDx Holdings Corp. Investors to Act: Class Action Filed Alleging Investor Harm

Indeterminate GlobeNewswire

Jun. 14, 2026

Bronstein, Gewirtz & Grossman LLC Urges Regencell Bioscience Holdings Ltd. Investors to Act: Class Action Filed Alleging Investor Harm

Indeterminate GlobeNewswire

Jun. 14, 2026

Bronstein, Gewirtz & Grossman LLC Urges POET Technologies Inc. Investors to Act: Class Action Filed Alleging Investor Harm

Indeterminate GlobeNewswire

Jun. 14, 2026

Bronstein, Gewirtz & Grossman LLC Urges Lucid Group, Inc. Investors to Act: Class Action Filed Alleging Investor Harm

Indeterminate GlobeNewswire

Jun. 14, 2026

Bronstein, Gewirtz & Grossman LLC Urges Verra Mobility Corporation Investors to Act: Class Action Filed Alleging Investor Harm

Indeterminate GlobeNewswire

Jun. 14, 2026

Bronstein, Gewirtz & Grossman LLC Urges Zillow Group, Inc. Investors to Act: Class Action Filed Alleging Investor Harm

Indeterminate GlobeNewswire

Jun. 14, 2026

Modat adds Passive DNS to its Platform Magnify, Connecting Every Signal in a Single Investigation Graph

Indeterminate GlobeNewswire

Jun. 14, 2026

Celldex Presents Long-Term Barzolvolimab Results Demonstrating Sustained Off-Treatment Improvement in Angioedema in Patients with CSU at the European Academy of Allergy and Clinical Immunology Annual Meeting

Indeterminate GlobeNewswire

Jun. 14, 2026

Mineralys Therapeutics Presents Late-Breaking Data on Lorundrostat and Heart Failure Risk Biomarkers at The Endocrine Society Annual Meeting (ENDO 2026)

Indeterminate GlobeNewswire

Jun. 14, 2026

Upstream Bio Presents New Responder Analyses Demonstrating Clinically Meaningful Improvements in CRSwNP in Significant Majority of Participants Treated with Verekitug in the Phase 2 VIBRANT Trial at EAACI 2026

Indeterminate GlobeNewswire

Jun. 14, 2026

Menarini Group Reports Data from the Phase 3 SENTRY Trial of Selinexor (NEXPOVIO®) Plus Ruxolitinib in Myelofibrosis at The European Hematology Association (EHA) 2026 Congress

Indeterminate GlobeNewswire

Jun. 14, 2026

Celldex Presents Positive First-in-Human Results from Phase 1 Study of Novel Bispecific CDX-622 at the European Academy of Allergy and Clinical Immunology Annual Meeting

Indeterminate GlobeNewswire